Tekla Capital Management LLC I Teos Therapeutics, Inc. Transaction History
Tekla Capital Management LLC
- $2.53 Billion
- Q2 2023
A detailed history of Tekla Capital Management LLC transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Tekla Capital Management LLC holds 45,735 shares of ITOS stock, worth $464,210. This represents 0.02% of its overall portfolio holdings.
Number of Shares
45,735
Previous 45,735
-0.0%
Holding current value
$464,210
Previous $622,000
2.73%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding ITOS
# of Institutions
17Shares Held
4.31MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY3.73MShares$37.9 Million0.0% of portfolio
-
Eagle Asset Management Inc St Petersburg, FL152KShares$1.54 Million0.01% of portfolio
-
Ea Series Trust Havertown, PA101KShares$1.03 Million0.05% of portfolio
-
Fny Investment Advisers, LLC65KShares$659,7500.27% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL60.4KShares$613,0700.0% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $361M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...